Lista de obras -

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

artículo científico publicado en 2017

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

artículo científico publicado en 2017

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

artículo científico publicado en 2015

Arterial lesions in giant cell arteritis: A longitudinal study

artículo científico publicado en 2018

Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes

artículo científico publicado en 2020

Association of diabetes-related autoantibodies with the incidence of asthma, eczema and allergic rhinitis in the TRIGR randomised clinical trial

artículo científico publicado en 2020

Cardiac Involvement in Granulomatosis with Polyangiitis

artículo científico publicado en 2015

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

scientific article published on 03 October 2019

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

artículo científico publicado en 2015

Efficacy of leflunomide in the treatment of vasculitis

scientific article published on 10 November 2020

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

scientific article published on 01 September 2019

Evaluation of damage in giant cell arteritis

artículo científico publicado en 2017

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

artículo científico publicado en 2019

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

artículo científico publicado en 2016

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

artículo científico publicado en 2015

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

scientific article published on 03 December 2020

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

artículo científico publicado en 2017

New features of disease after diagnosis in 6 forms of systemic vasculitis

artículo científico publicado en 2013

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

artículo científico publicado en 2019

Patterns of clinical presentation in Takayasu's arteritis

artículo científico publicado en 2020

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

artículo científico publicado en 2018

Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2

artículo científico publicado en 2020

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

artículo científico publicado en 2015

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

artículo científico publicado en 2019

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

artículo científico publicado en 2018

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

artículo científico publicado en 2019

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis

artículo científico publicado en 2016

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2020

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis

artículo científico publicado en 2014

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature

artículo científico publicado en 2015

urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

artículo científico publicado en 2013

Lista de obras de

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis

A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Takayasu Arteritis

A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility ⬇️

Arterial lesions in giant cell arteritis: A longitudinal study

Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes

Association of diabetes-related autoantibodies with the incidence of asthma, eczema and allergic rhinitis in the TRIGR randomised clinical trial

Cardiac Involvement in Granulomatosis with Polyangiitis

Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America

Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.

Efficacy of leflunomide in the treatment of vasculitis

Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis

Evaluation of damage in giant cell arteritis

Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) in Systemic Vasculitis

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome-Wide Association Study

Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

IgA antibodies to myeloperoxidase in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

New features of disease after diagnosis in 6 forms of systemic vasculitis

Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis

Patterns of clinical presentation in Takayasu's arteritis

Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis

Sequence-based screening of patients with idiopathic polyarteritis nodosa, granulomatosis with polyangiitis, and microscopic polyangiitis for deleterious genetic variants in ADA2

Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma

Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis

Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis

The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis

Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis

Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis

Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature

urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis